Drug Trial Radar · NCT05275972
Descemet Endothelial Thickness Comparison Trial II
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
60
Actual
Start
Jan 23, 2023
Primary completion
Oct 30, 2027
Study completion Oct 30, 2028
Sponsor
- Lead sponsor
- Stanford UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Oregon Health and Science University; University of California, San Francisco; University of California, Davis; Case Western Reserve University; Dartmouth-Hitchcock Medical Center; University of Pennsylvania; University of Miami; Wills Eye Hospital; Devers Eye Institute
- First posted
- Mar 11, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.
Conditions
- Fuchs
- Fuchs Dystrophy
- Fuchs' Endothelial Dystrophy
Interventions
RipasudilDrug
Topical Ripasudil 0.4%
PlaceboDrug
Topical Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Best spectacle-corrected visual acuity (BSCVA)Time frame: 12 months
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
University of California Davis
Sacramento, California
University of Miami
Palm Beach Gardens, Florida
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Legacy Devers Eye Institute
Portland, Oregon
Oregon Health & Science University
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
Wills Eye Hospital
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.